Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

One-Quarter of Every U.S. Healthcare Dollar Wasted

Linda Carroll  |  October 15, 2019

(Reuters Health)—About a quarter of the dollars spent on healthcare in the U.S. may be wasted, a new analysis suggests. Six types of waste in healthcare could be costing as much as $935 billion annually, according to the study published in JAMA.1,2 The biggest source of waste is “administrative complexity,” says the study’s lead author…

Filed under:Professional Topics Tagged with:cost of health carecostsHealthcaremoney

Mortality from Anti-neutrophil Cytoplasmic Autoantibody-Associated Vasculitis Falling Slightly

Will Boggs, MD  |  October 9, 2019

NEW YORK (Reuters Health)—Mortality rates in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) decreased from 1999 to 2017, according to records from the Centers for Disease Control and Prevention (CDC). “The mortality attributed to several rare diseases [e.g., hypersensitivity pneumonitis] has increased in recent years,” Alexander W. Steinberg, MD, from Saint Joseph Hospital, Denver, tells…

Filed under:ConditionsVasculitis Tagged with:AAVGPAmortalitymortality rate

Lupus Flares Pose Greatest Risk for Adverse Pregnancy Outcomes in Women with SLE

Lara C. Pullen, PhD  |  October 7, 2019

According to new research, women with SLE are at the highest risk for adverse pregnancy outcomes during a lupus flare. The data may enable clinicians to use risk stratification and tailored monitoring to counsel SLE patients who are pregnant or considering pregnancy. Researchers also found that maternal age, lupus nephritis and antiphospholipid antibodies may affect pregnancy outcomes…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:flareFlaresLupusOutcomespregnancypregnancy complicationspregnant womenWomen

Nintedanib Slows Lung Deterioration in General Fibrosing Interstitial Lung Disease

Reuters Staff  |  October 2, 2019

NEW YORK (Reuters Health)—Nintedanib dramatically slows lung deterioration in patients with progressive fibrosing interstitial lung diseases, according to a new randomized study.1 Nintedanib has already been shown to be effective against idiopathic pulmonary fibrosis (IPF). The new trial, funded by the manufacturer, Boehringer Ingelheim, and presented t the European Respiratory Society International Congress 2019 in…

Filed under:Drug Updates Tagged with:ILDInterstitial Lung Diseaselung diseaselungsnintedanib

RheumPAC Advocates for Dept. of Defense Arthritis Research Funding

From the College  |  September 17, 2019

RheumPAC is the ACR’s non-partisan political action committee, which promotes the needs of rheumatology providers and patients. Advocacy efforts often focus on legislation to improve the day-to-day clinical care of rheumatology patients, such as establishing clinical exceptions to step therapy requirements and reforming the prior authorization process. In addition, the ACR and RheumPAC recognize the…

Filed under:From the CollegeLegislation & AdvocacyOsteoarthritis and Bone Disorders Tagged with:DoD research fundingResearch FundingRheumPAC

Summer 2019’s Awards, Appointments & Announcements in Rheumatology

Gretchen Henkel  |  September 17, 2019

Betty Diamond, MD, Recognized as Distinguished Fellow by American Association of Immunologists At its annual meeting in May in San Diego, the American Association of Immunologists (AAI) recognized Betty Diamond, MD, as a distinguished fellow. Dr. Diamond is professor and head of the Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases at the Feinstein Institutes for…

Filed under:AwardsProfiles Tagged with:Dr. Betty DiamondDr. Eric L. MattesonDr. Jinoos YazdanyMovers & Shakers

Our New Executive Vice President Discusses His Aspirations for the ACR

Steven C. Echard, IOM, CAE  |  September 17, 2019

I was honored to be invited by Paula to write this column about my aspirations for the ACR’s future. As one might expect, I am also humbled by the prospect of trying to encapsulate the vision that has already been so elegantly provided by ACR leadership and its board of directors: “As the leading authority…

Filed under:President's Perspective Tagged with:LeadershipSteven C. Echard

Stealing Time

Philip Seo, MD, MHS  |  September 17, 2019

I knew I shouldn’t look. I was driving 60 miles per hour, heading north on I-95, trying to get to the George Washington Bridge before dusk. It takes a certain fatalism to drive through New York City if you are not a native. Ninety percent of the drivers sharing the road with you know exactly…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:burnoutpatient-centered care

AJPhoto / Science Source

Tips for Diagnosing Metabolic Myopathies

Ruth Jessen Hickman, MD  |  September 17, 2019

When evaluating patients with possible myopathic symptoms, rheumatologists must consider a rare, but important, group of inherited disorders: the metabolic myopathies. However, their diagnosis often remains a challenge. Early recognition of these primary metabolic myopathies is essential to help prevent disease morbidity and mortality from rhabdomyolysis. Here, we focus on the metabolic myopathies that present…

Filed under:Conditions Tagged with:creatinine kinesegenetic diseasegenetic disordersMetabolic Myopathiesrhabdomyolysis

ACR on Air: New Rheumatology Podcast Introduced

Susan Bernstein  |  September 2, 2019

A new podcast from the ACR provides in-depth discussions about newly published science, regulatory updates, advocacy and volunteer opportunities for the rheumatology community…

Filed under:Education & Training

  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 125
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences